EuroPLX 78 Lisbon

April 4, 2022 - April 5, 2022


The regulatory landscape for generic topical products has significantly evolved in recent years. Opportunities are opening in the USA and Europe for generic approvals by demonstrating in vitro bioequivalence, as opposed to utilising the risky and expensive clinical bioequivalence route.

MedPharm has led the way in pioneering this approach to generic drug product development. Connect with MedPharm at EuroPLX 78 to learn why the scientific integrity of our work is respected by regulatory authorities and inspired credibility and confidence in a client’s submission.

Get in Touch

Connect with a member of our team at the event, through the event platform, or send us an email at to schedule a meeting!